Scilex Sues Over Alleged $100M+ Securities Fraud Involving 96M Datavault Shares
Event summary
- Scilex filed a federal securities fraud lawsuit on March 13, 2026, alleging misappropriation of 96M Datavault AI shares pledged as collateral.
- The lawsuit targets Marc Wade, St. James Bank, Omega & Corinth Group, and BNY Mellon for allegedly selling the shares without authorization.
- Scilex seeks recovery of the shares, compensatory damages exceeding $100M, punitive damages, and disgorgement of profits.
- The alleged scheme involved transferring the shares into unauthorized brokerage accounts at BNY Mellon and selling them into the public market.
The big picture
Scilex's lawsuit highlights the risks of securities fraud in stock loan transactions, particularly involving high-value collateral. The case underscores the importance of safeguarding pledged assets and the potential financial and reputational damage from unauthorized trading activities. The outcome could influence industry practices in collateral management and brokerage account oversight.
What we're watching
- Litigation Outcome
- The pace at which Scilex can recover the misappropriated shares or secure damages will impact its financial stability and strategic focus.
- Market Impact
- The alleged trading activity's effect on Datavault AI's share price and market dynamics will be a key factor to monitor.
- Regulatory Scrutiny
- Whether this case draws increased regulatory attention to stock loan agreements and collateral management practices.
Related topics